جستجوی استاد راهنمای دانشگاهی

Clovis Palmerمشاهده پروفایل

استادیار

• Immunometabolism
• HIV Pathogenesis
• Aging and Infectious Diseases
• +۳ مورد دیگر

Clovis Palmer, PhD, is an Assistant Professor of Microbiology and Immunology at Tulane University, affiliated with the Tulane National Primate Research Center. His research focuses on immunometabolism in HIV, aging, and viral infections. He holds a BS in Biochemistry and Botany from the University of the West Indies and a PhD in Molecular Biology from the University of Sydney. His work explores how metabolic processes influence HIV persistence, immune dysfunction, and aging. Key areas include identifying metabolic biomarkers for HIV control, studying HIV's impact on accelerated aging, and investigating metabolic complications of COVID-19. He has developed technologies like Met-Spectre for single-cell metabolic analysis. Palmer's awards include the Tulane Health Sciences Auxiliary Endowment (2023-2026) and recognition as an Emerging Leader in HIV Research by NIH/IAS (2017). He has delivered keynote lectures globally on HIV immunometabolism and aging. His research integrates non-human primate models with human clinical data, emphasizing translational applications for metabolic therapies targeting HIV cure and aging-related comorbidities.

• Medical Biometry
• Epidemiology
• Cognitive Dysfunction
• +۴ مورد دیگر

Insa Feinkohl is a Professor at the Chair of Medical Biometry and Epidemiology within the Faculty of Health at the University of Witten/Herdecke . Her research focuses on risk factors for cognitive dysfunction and mental health in older adults, particularly post-surgery, with emphasis on metabolic and cognitive risk factors. Bachelor of Science (BSc) in Psychology (1 st class honors) – University of Dundee (2006-2009) Master of Science (MSc) in Psychology of Individual Differences (with distinction) – University of Edinburgh (2009-2010) PhD in Community Health Sciences – University of Edinburgh (2010-2014) Post Doc in Knowledge Construction Group – Leibniz Institute for Knowledge Media, Tübingen (2014-2015) Postdoc in Molecular Epidemiology Group – Max Delbrück Center, Berlin (2015-2022) Habilitation in Molecular Epidemiology – Charité Universitätsmedizin Berlin (2021) Her research integrates medical biometry and epidemiology to study postoperative cognitive dysfunction (POCD), delirium, and aging-related cognitive decline. Key areas include biomarker validation (e.g., leptin, interleukins), brain connectivity (dopaminergic networks, thalamus), and metabolic risk factors (diabetes, obesity). She contributed to the BioCog project , an EU-funded initiative for personalized risk prediction of postoperative cognitive impairment. Her recent publications highlight trends in perioperative neuroscience, including brain mineralization, cytokine associations with neurocognitive disorders, and structural/functional imaging in delirium. Articles also explore metabolic syndrome, cognitive reserve, and delirium prediction models using machine learning. Insa Feinkohl is affiliated with major academic societies, including the German Society for Epidemiology , German Society for Medical Informatics, Biometry and Epidemiology , and the German University Association .

Reilly T. Enosمشاهده پروفایل

استادیار

• Obesity
• Metabolic Disease
• Sex Differences in Metabolism
• +۹ مورد دیگر

Reilly T. Enos, PhD, is an Assistant Professor in the Department of Pathology, Microbiology & Immunology at the University of South Carolina School of Medicine. His research focuses on the molecular mechanisms of sex differences in obesity, particularly metabolic and inflammatory processes influenced by sex steroids. The Enos Lab employs rodent models and advanced metabolic phenotyping to investigate menopause-related metabolic dysfunction and complementary therapies. PhD, Exercise Science (Applied Physiology), University of South Carolina, 2013 Post-Doctoral, Complementary and Alternative Medicine in Cancer and Obesity, University of South Carolina School of Medicine, 2017 MS, Exercise Physiology, Baylor University, 2009 BS, Dietetics, University of Northern Colorado, 2010 BA, Spanish & Physical Education, College of Wooster, 2007 Dr. Enos’s research spans immunometabolism, obesity, cancer cachexia, and gut microbiota. His work explores how dietary components (e.g., quercetin, emodin), hormonal status (especially estrogen), and immune modulation (e.g., miR-155, macrophages) influence metabolic and oncological outcomes. He investigates sex-specific responses to high-fat diets, inflammation, and therapeutic interventions using transgenic and diet-induced mouse models. His recent publications highlight trends in metabolic physiology, inflammation, and cancer, often examining the interplay between adipose tissue, immune cells, and hormonal regulation. Key themes include the impact of vivarium conditions on reproducibility, the role of microRNAs in tumorigenesis, and the safety and efficacy of natural compounds. Dr. Enos has not been awarded any listed scientific prizes or fellowships in the provided texts. He advises a research team focused on metabolic and inflammatory disease models, frequently collaborating with researchers such as Erin A. Murphy and Kandy T. Velázquez. His lab receives funding for studies on obesity, cancer, and complementary medicine, though specific grants are not detailed. The lab is equipped for metabolic phenotyping and rodent model studies. The Enos Lab is dedicated to understanding sex-specific metabolic regulation and developing targeted therapies for obesity and cancer-related metabolic disorders, with a focus on translational relevance and experimental rigor.

• Hepatocellular Carcinoma
• Liver Cancer Stem Cells
• Adiponectin Signaling
• +۶ مورد دیگر

Lionel Hebbard is a Professor in the Department of Molecular and Cellular Biology at James Cook University's College of Medicine and Dentistry. His research spans hepatocellular carcinoma mechanisms, metabolic liver disease, and cancer therapeutics with significant contributions to adiponectin biology and sarcopenia assessment in cardiac surgery. James Cook University (Current) Department of Molecular and Cellular Biology College of Medicine and Dentistry Senior Researcher in Liver Cancer Biology His research focuses on hepatocellular carcinoma pathogenesis , particularly adiponectin signaling pathways and liver cancer stem cells. He investigates non-alcoholic fatty liver disease progression to cancer, metabolic drivers of tumorigenesis, and therapeutic targeting using aptamer-based delivery systems. Recent work explores sarcopenia quantification via CT imaging for cardiac surgery risk prediction, demonstrating clinical translation of his molecular findings. His lab employs advanced techniques including CRISPR screening (TARGET-SL platform), in vitro cancer models, and murine tumor systems. Analysis of his 15 most recent publications reveals strong emphasis on translational liver cancer research (60%), cardiac surgery complications (20%), and emerging biotechnologies (20%). Key trends include adiponectin's dual roles in fibrosis and tumorigenesis, sarcopenia as a surgical biomarker, and aptamer-based targeting of cancer stem cells. His work consistently bridges molecular mechanisms with clinical applications, particularly in hepatocellular carcinoma diagnostics and treatment. He mentors multiple doctoral students and early-career researchers including Rhys Gillman and Miriam Wankell. His research is supported by continuous funding from Australian NHMRC and international collaborations with George Jacob (Westmead Institute), Qiao Liang (Bentham Books), and Ranscht Barbara (T-cadherin studies). He leads the Hepatic Cancer Biology laboratory focusing on: Liver cancer stem cell characterization Adiponectin receptor signaling in HCC Metabolic drivers of tumor progression Novel drug delivery systems for liver cancer Translational sarcopenia assessment tools

• Metabolic Health in Obesity
• Nonalcoholic Fatty Liver Disease (NAFLD)
• Hepatokine Research
• +۵ مورد دیگر

Prof. Norbert Stefan is a Full Professor at the University of Tübingen's Department of Internal Medicine IV, specializing in clinical and experimental diabetology. His work focuses on metabolic health in obesity, nonalcoholic fatty liver disease (NAFLD), and hepatokine research. Pioneered metabolic phenotyping studies in the Tübingen Lifestyle Intervention Program (TULIP) Conducted seminal NIH/NIDDK research on adiponectin's role in insulin resistance in Pima Indian populations Developed the concept of hepatokines in 2008 with his colleagues His 2025 publications span GLP-1 receptor agonists' effects on liver fibrosis, SGLT2 inhibitors' impact on liver events, and precision medicine approaches for metabolic dysfunction-associated steatotic liver disease. Current research integrates urinary peptidomics, brain insulin action studies, and advanced visceral fat quantification techniques. Scientific Awards Innovation Award of the German Society for University Medicine (2010) Heisenberg-Professorship for Clinical and Experimental Diabetology (2011) Editorial Board Member, The Lancet Diabetes & Endocrinology (2015) Senior Associate Editor, Diabetes (2021) Stefan maintains collaborative networks with Harvard Medical School, Boston Children's Hospital, the NIH, and consortia like SOPHIA IMI EU Consortium and the German Center for Diabetes Research.

Elin Nymanمشاهده پروفایل

دانشیار

• Systems Biology
• Biomedical Engineering
• Drug Development
• +۳ مورد دیگر

Elin Nyman is the Head of the Department of Biomedical Engineering (IMT) and an Associate Professor at Linköping University. She leads the department, fostering an environment of trust and collaboration. Her research focuses on systems biology and e-health, integrating mathematical models with experimental data to advance drug development and clinical tools. She supervises students in both the Faculty of Science and Engineering and the Faculty of Medicine and Health Sciences, examining courses like TMBI28 and 8BKG45. Her research interests include systems biology, particularly in drug development and AI applications in healthcare. Key projects involve robust metabolic measurements, AI-driven diagnostic tools (M4-health), and knowledge-driven drug development with AstraZeneca. Recent publications highlight liver steatosis dynamics, IL-10 feedback mechanisms, and insulin resistance modeling. Her work bridges interdisciplinary collaboration, such as a course combining medical and engineering students to develop digital health solutions. She contributed to a SEK 13 million grant for AI-based crime-solving using detailed analyses and AI. Current affiliations include the Division of Biomedical Engineering (MT) and IMT department.

Miles De Blasioمشاهده پروفایل

پژوهشگر ارشد

• Diabetes
• Cardiomyopathies
• Diabetic Complications
• +۶ مورد دیگر

Miles De Blasio is a Research Fellow in Drug Discovery Biology at Monash Institute of Pharmaceutical Sciences (MIPS), Monash University. He also holds adjunct and honorary roles as an Adjunct Research Fellow in Pharmacology at MIPS, Honorary Research Collaborator at the Baker Heart and Diabetes Institute, and Honorary Research Fellow at Monash Clayton’s Department of Pharmacology. His research focuses on novel therapies for diabetic cardiomyopathy, leveraging pharmacological agents and cardiac-selective gene therapies targeting pathways like the hexosamine biosynthesis pathway and adiponectin signaling. De Blasio earned his PhD in 2004 from the University of Adelaide, studying diabetes and obesity origins in fetal growth-restricted sheep. He later worked at the University of Cambridge, exploring fetal leptin’s role in lung and heart development, before shifting to diabetic cardiomyopathy in 2015. Since 2020, he leads MIPS’ efforts to develop cardioprotective treatments. His research interests emphasize translational cardiology and metabolic disease, with a focus on sex-specific differences, preclinical models, and therapeutic interventions. Projects include developing mouse models for diabetic cardiomyopathy and investigating next-generation glucose-lowering therapies’ cardiac benefits. He has secured over $7 million in grants as a Chief Investigator and supervised 10 PhD and 15 Honours students. His work contributes to UN Sustainable Development Goals related to health and well-being. Key Awards: Novartis Junior Investigator Award (Finalist, 2001) Ross Wishart Award (Finalist, 2001) Second Place, IGF Down Under Symposia Oral Presentation (2006) Second Place, GH-IGF International Conference Oral Presentation (2004) New Investigator Award, PSANZ (2002) Advising & Grants: De Blasio has supervised numerous students and secured major funding through NHMRC grants and Diabetes Australia. His labs, including the Cardio-Metabolic Physiology Lab and co-headed Heart Failure Pharmacology Lab, drive interdisciplinary research in drug discovery and cardiac protection. Labs & Collaborations: He leads the Cardio-Metabolic Physiology Laboratory at MIPS, collaborating with institutions like the Baker Heart and Diabetes Institute. Research spans cellular/molecular cardiology, mitochondrial function, and gene therapy applications in diabetes-related heart failure.

• Diabetes Mellitus
• Endocrinology
• Metabolism
• +۶ مورد دیگر

Silvio Inzucchi, MD , is Professor of Medicine (Endocrinology) at Yale University School of Medicine , where he serves as Clinical Chief of the Section of Endocrinology, Medical Director of the Yale Diabetes Center, and Program Director of the Endocrinology & Metabolism Fellowship. He is a leading expert in diabetes management, with a focus on pharmacological therapies and cardiovascular outcomes. Education: BS, Fordham University (1981) MD, Harvard Medical School (1985) Residency, Internal Medicine, Yale-New Haven Hospital Fellowship, Endocrinology and Metabolism, Yale-New Haven Hospital Dr. Inzucchi’s research centers on clinical diabetes management , particularly pharmacological antihyperglycemic therapy and the cardiovascular complications of type 2 diabetes and insulin resistance . His work bridges clinical practice and large-scale trials, aiming to improve patient outcomes through evidence-based strategies. He has been instrumental in shaping national and international guidelines, including co-chairing the 2012 and 2015 ADA-EASD Position Statements on Hyperglycemia in Type 2 Diabetes. His recent publications reflect a strong trend in cardiovascular and renal outcomes of diabetes medications, especially SGLT2 inhibitors and GLP-1 receptor agonists. These studies, published in top journals like Circulation , JAMA Cardiology , and Diabetes Care , often involve meta-analyses of major trials such as SOUL, DAPA-HF, and DELIVER, highlighting the real-world impact of these therapies on heart failure, kidney function, and quality of life. Scientific Awards and Recognition: David J. Leffell Prize for Clinical Excellence, Yale University Named 'Top Doctor' by local and national rankings Dr. Inzucchi is actively involved in clinical mentoring and education as Fellowship Program Director and through his academic clinical practice. He has led and participated in numerous federally and industry-funded clinical trials , contributing to the advancement of diabetes therapeutics. His work is supported by affiliations with the Yale Diabetes Center , Diabetes Research Center , and Yale Center for Clinical Investigation (YCCI) . He is a frequent national and international speaker on diabetes management and has served on editorial boards for Diabetes Care and the Journal of Clinical Endocrinology and Metabolism .

• Vascular Biology
• Atherosclerosis
• Arterial Stiffness
• +۲ مورد دیگر

Dr. Stella Daskalopoulou is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and a Professor in the Department of Medicine at McGill University's Faculty of Medicine and Health Sciences. She specializes in translational cardiovascular research with a focus on vascular health, atherosclerosis, and hypertension management. Senior Scientist, RI-MUHC Glen site Professor, Department of Medicine, McGill University Member, Cardiovascular Health Across the Lifespan Program Research Focus: Her work integrates biomedical technology with clinical investigation to identify early vascular impairment markers. Key areas include: Arterial stiffness and hemodynamic assessment Adiponectin signaling pathways in atherosclerosis Sex-specific cardiovascular risk stratification Biomarker discovery for plaque instability Pregnancy-related vascular complications Machine learning applications in plaque classification Scientific Engagement: Dr. Daskalopoulou contributes to hypertension guideline development (2024 ESC Guidelines) and explores environmental impacts on vascular health (household pollution studies). Her recent publications emphasize: Deep learning for plaque characterization Sex hormone receptor pathways in atherosclerosis Adipokine interactions with HDL metabolism Clinical decision tools for preeclampsia prediction Laboratory: Leads the Vascular Health Unit at RI-MUHC, combining histopathology, immunophenotyping, and advanced imaging for translational research.

Lindsay Robinsonمشاهده پروفایل

استاد

• Nutrition
• Metabolism
• Adipokines
• +۳ مورد دیگر

Dr. Lindsay Robinson is a Professor in the Department of Human Health and Nutritional Sciences at the University of Guelph. Her research focuses on the integration of diet and exercise in mediating metabolic processes in health and chronic diseases, particularly obesity and type 2 diabetes. She holds a B.Sc. from Acadia University and a Ph.D. from the University of Alberta, followed by an NSERC Postdoctoral Fellowship at the University of Guelph. Her work examines adipose tissue-derived cytokines (adipokines) and their roles in metabolic communication between tissues. Current projects investigate the effects of n-3/n-6 fatty acids, exercise, and dietary interventions on inflammation and insulin resistance. Her lab is funded by NSERC and the Canadian Foundation for Innovation. Key research contributions include studies on omega-3 fatty acids’ anti-inflammatory effects, adiponectin regulation, and the role of dietary components like navy beans and apples in mitigating metabolic dysfunction. She has supervised MSc students in these areas and collaborates widely in nutritional biochemistry. Her publications span over two decades, emphasizing translational research between basic science and clinical applications. Awards and grants reflect sustained excellence in metabolic nutrition research.

Soner Doğanمشاهده پروفایل

استاد

• Breast Cancer
• Calorie Restriction
• Molecular Biology
• +۳ مورد دیگر

Prof. Soner Doğan is a Professor at Yeditepe University's Faculty of Medicine, Department of Medical Biology. He holds a PhD in Medical Biology from the University of Minnesota and a Bachelor's in Veterinary Science from Ankara University. His research bridges oncology, epigenetics, and metabolic regulation, with a focus on breast cancer mechanisms and calorie restriction. Research interests span: Breast Cancer Pathobiology : Investigating leptin/adiponectin signaling and epigenetic modifications in tumor development. Calorie Restriction : Examining intermittent vs. chronic dietary interventions for cancer prevention and aging. Aging and Frailty : Identifying biomarkers and molecular pathways in age-related diseases using murine models. His publications emphasize molecular oncology, with recurring themes in adipokine signaling, DNA methylation, and transcriptomic profiling. Articles frequently utilize transgenic mouse models and RNA-seq to explore metabolic and immune interactions in cancer. Awards & Honors: Professional Development Grant, Education Minnesota Foundation AICR Scholarship for Cancer Research Conference Advising & Grants : Supervised 11+ Master's/PhD theses on topics like nanoparticle drug delivery and epigenetic regulation. Secured major grants including TÜBİTAK 1001 (€395K) for breast cancer epigenetics and COST Action CA17129 for cardiovascular transcriptomics. Affiliations : Leads projects at Yeditepe’s molecular biology labs and collaborates internationally (e.g., EU-CardioRNA COST Action). Holds administrative roles as Department Coordinator and Ethics Committee member.

Utpal Palمشاهده پروفایل

استاد

• Lyme disease
• Leptospirosis
• Vector Biology
• +۷ مورد دیگر

Dr. Utpal Pal is a Professor in the Department of Veterinary Medicine at the University of Maryland, College Park , where he has served since 2006. He is also an Affiliate Professor in the Department of Entomology at the same institution. Dr. Pal directs the Veterinary Medical Sciences (VMSC) Graduate Program (2016-2019) and leads the Tick Immunity research initiative. Education: M.Sc. (1988), Ph.D. (1994) from University of Calcutta, Postdoctoral Training (2002) at Yale University Research Focus : Dr. Pal investigates molecular mechanisms of vector-borne diseases , particularly Lyme disease and Leptospirosis . His work explores genetic determinants of Borrelia burgdorferi and Leptospira interrogans , emphasizing host-vector-pathogen interactions , immunomodulation , and next-generation therapeutics . His lab employs genomics, proteomics, and structural biology to uncover pathogenesis pathways and vaccine targets. Dr. Pal's recent research trends include: Tick immune signaling (Dome1-JAK-STAT pathway) Genomic analysis of Ixodes scapularis Epigenetic regulation in vector biology Novel vaccine strategies (mRNA, protein targets) Proteolytic processing of virulence factors Tick gut barriers and microbiome-pathogen dynamics Funding Sources : His work has been supported by NIH-NIAID NIH-NIAMS American Heart Association Arthritis Foundation Department of Defense Cohen Foundation Global Lyme Alliance MAES Merck Lab Members : The Pal Lab includes 8 active graduate students specializing in Lyme disease pathogenesis, tick immunity, and microbial persistence , along with research scientists and faculty specialists.

Chi Wangمشاهده پروفایل

استاد

• Cancer Biostatistics
• Bioinformatics
• Survival Analysis
• +۱۰ مورد دیگر

Chi Wang, Ph.D., is Professor of Internal Medicine and Statistics at the University of Kentucky, Associate Director of the Biostatistics & Bioinformatics Shared Resource, and a lead computational scientist within the Markey Cancer Center. With an h-index of 39 and >5,300 citations, he develops cutting-edge survival-analysis and high-dimensional-omics methods that are translated into prostate, breast, lung and neuroblastoma trials. Education: Ph.D. Biostatistics, Johns Hopkins University, 2009 M.S. Statistics, Peking University, 2003 B.S. Mathematics, Peking University, 2001 Research Focus: Wang’s group integrates Bayesian statistics, machine-learning and single-cell sequencing to model tumor evolution, drug resistance and biomarker-driven adaptive trials. Major themes include enzalutamide resistance in prostate cancer, PLK1-mediated immune evasion in lung adenocarcinoma, obesity-adipose drivers of breast cancer, and epigenetic reprogramming of tumor-infiltrating lymphocytes. Recent Article Trends (2023-2025): Fifteen showcased papers reveal a dual trajectory—(1) mechanistic dissection of kinases (PLK1, DDR1, ABL1/2) and metabolic enzymes (FASN, NNMT, HSP47) that orchestrate resistance and metastasis, and (2) probabilistic algorithms for temporal mutation ordering, biomarker evaluation and single-cell deconvolution. Overarching keywords are precision oncology, drug resistance, tumor micro-environment, and computational systems biology. Funding & Awards: He is PI/co-I on 152 grants (32 active) from NCI, ACS, V Foundation, etc., totaling >$30 M direct costs. Highlights include NCI U01 for predictive biomarkers, American Cancer Society award on collagen lysyl hydroxylase metastasis drivers, and NCI R01s targeting NNMT in triple-negative breast cancer and TIL epigenetic reprogramming in NSCLC. Student & Team Mentorship: Wang trains a large multi-disciplinary cohort of Ph.D. students, post-docs and clinical fellows who routinely lead first-author papers and are funded on his grants. His lab sits within the Markey Cancer Center’s Molecular & Cellular Oncology program and the Center for Computational Sciences, fostering daily bench-to-bedside collaboration.

Peter Backxمشاهده پروفایل

استاد

• Cardiac Physiology
• Cardiac Electrophysiology
• Arrhythmias
• +۴ مورد دیگر

Peter Backx is a Full Professor in the Department of Biology at York University and Canada Research Chair in Cardiovascular Biology. He is also an Emeritus Professor at the University of Toronto and a Senior Scientist at the University Health Network. His academic journey includes a B.Sc., M.Sc., DVM (University of Guelph), and Ph.D. (University of Calgary), followed by postdoctoral training at Johns Hopkins University. His research focuses on cardiac physiology, ion channels, arrhythmias, and stem cell applications in cardiovascular biology. Dr. Backx has secured over $14M in research funding and published over 200 articles in top journals. He has supervised 26 graduate students and 17 postdoctoral fellows. His awards include Fellowships from the Royal Society of Canada and American Heart Association, as well as the Lowell Langille Mentorship Award. His work emphasizes mechanisms underlying heart disease, including atrial fibrillation and heart failure, with a focus on translational applications like tissue-specific drug delivery. Key research areas include ion transport, myocardial signaling, and cardiac development using pluripotent stem cells. He has pioneered models of atrial fibrillation and engineered cardiac tissues. Recent studies explore TNF-alpha’s role in exercise-induced atrial remodeling and therapeutic strategies for Duchenne muscular dystrophy. Dr. Backx’s labs integrate electrophysiology, proteomics, and tissue engineering to advance cardiovascular medicine.

• Energy Homeostasis
• Metabolic Disease
• Obesity
• +۶ مورد دیگر

Peter J. Havel is a Professor with joint appointments in the Departments of Molecular Biosciences and Nutrition at the University of California, Davis. He holds a D.V.M. and Ph.D. in Endocrinology from UC Davis. His research focuses on energy homeostasis, carbohydrate/lipid metabolism, and the role of endocrine systems in obesity, diabetes, and cardiovascular disease. His lab investigates pancreatic and gastrointestinal hormones, adipocyte hormones (e.g., leptin, adiponectin), and dietary factors like fructose and fat. He has developed the UCD-T2DM rat model to study type 2 diabetes and evaluates bariatric surgery effects on endocrine regulation. Education: B.S. in Zoology (University of Washington), D.V.M. (UC Davis), Ph.D. in Endocrinology (UC Davis). Research highlights include studies on high-fructose corn syrup's metabolic impacts, bariatric surgery outcomes, and the development of novel animal models. Awards include the 2009 Pfizer Visiting Professor in Obesity and the 2000 Shih-Chun Wang Award. Scientific contributions span over 150 peer-reviewed articles, including work on fructose-induced metabolic dysfunction, adipokine signaling, and translational nutrition biology. He serves on editorial boards for journals like Molecular Metabolism and Endocrinology , and is a member of professional societies such as the American Diabetes Association and The Endocrine Society. His lab, located in Meyer Hall, collaborates extensively on projects involving adipocyte biology, dietary interventions, and hormonal mechanisms. Current studies include investigating adropin's role in circadian cholesterol regulation and the metabolic benefits of ileal interposition surgery.